Abstract:Purpose:To investigate the values of three newer contrast enhanced MRI sequences including gadolinium-enhanced FLAIR MRI(CE FLAIR), dynamic contrast-enhanced MRI (DCE MRI) and perfusion- weighted MRI(PWI) by comparing their advantages and disadvantages respectively in the diagnosis of intracranial tumors. Methods:43 patients with intracranial tumors underwent DCE MRI, CE FLAIR and PWI respectively. The gadolinium-enhanced FLAIR, dynamic enhanced MR and perfusion-weighted MR images were evaluated independently by two radiologists for the number of examinations with one or more enhancing lesions, the number and location of enhancing lesions per examination, the detectability for different lesions in different locations, size and extent of the lesions. Results:Perfusion-weighted MR images showed poor quality and could not give a diagnosis in 5 of 43 cases because of heavy susceptibility artifacts. There were 47 lesions in the 38 cases. However, 41 lesions were found on CE FLAIR MR images and 42 on DCE MRI and 45 on PWI. 3 lesions(2 located in the subcortical area and 1 in paraventricle) were only revealed on the CE FLAIR images. 4 lesions in the basal ganglia area were only found on dynamic enhanced images. 7 lesions in the cerebral hemisphere were only found on perfusion-weighted images. So there were significant differences in revealing lesions of different locations with the three MR modalities(P0.05). Dynamic enhanced images showed better enhancement than CE FLAIR in 26 of 38 cases((68.4%)), whereas CE FLAIR images showed better enhancement in 3 cases and 9 cases demonstrated approximately equal contrast enhancement with both sequences. On the perfusion-weighted MR images, 36 of 38 cases showed enhancement and 2 showed no enhancement. The mean volume of lesions was 4.4±1.0cm~(3) on DCE MRI, 5.5±0.8cm~(3) on CE FLAIR and 5.7±1.3cm~(3) on PWI(P0.05). Conclusions:There are no significant differences in the number of examinations withone or more enhancing lesions displayed on the three sequences of CE FLAIR, DCE MRI and PWI. However, the location of enhancing lesions per examination and the size and extent of the lesions showed significant differences. CE FLAIR is superior in detecting lesions near the sulcuses or paraventricle. DCE MRI is superior in detecting lesions in the basal ganglia. And PWI is superior in detecting lesions in the cerebral hemisphere. The three newer contrast-enhanced techniques combining with conventional MR imaging may improve the detectability and diagnostic accuracy of intracranial tumors.

Evaluation of Postcontrast Images of Intracranial Tumors at 7T and 3T MRI: an Intra‐individual Comparison Study

Accuracy of UTE-MRI-based patient setup for brain cancer radiation therapy.

7T MRI with Post-Processing for the Presurgical Evaluation of Pharmacoresistant Focal Epilepsy.

Applications of Three Newer Contrast-Enhaced MRI Sequences in the Diagnosis of Intracranial Tumors

Primary intracranial tumor imaging: a comparison of magnetic resonance and CT.

Ultra-High-Field MRI in the Diagnosis and Management of Gliomas: A Systematic Review

Exploring the Potential of Ex-vivo 7-T MRI on Patients with Clinically Significant Prostate Cancer: Visibility and Size Perspective

Diagnostic Value of Contrast-Enhanced Fluid-Attenuated Inversion-Recovery MRI for Intracranial Tumors in Comparison with Post-Contrast T1W Spin-Echo MRI

[Preoperative T Stage of Non-Small Cell Lung Cancer: Comparison of the Efficacy of 64-MDCT Versus 3.0T MR Imaging].

The Presurgical T Staging of Non-Small Cell Lung Cancer: Efficacy Comparison of 64-MDCT and 3.0 T MRI.

Exploring the Feasibility of Integrating Ultra‐high Field Magnetic Resonance Imaging Neuroimaging with Multimodal Artificial Intelligence for Clinical Diagnostics

Comparison of dynamic susceptibility contrast (DSC) using gadolinium and iron-based contrast agents in high-grade glioma at high-field MRI

Value of 7T MRI and post‐processing in patients with nonlesional 3T MRI undergoing epilepsy presurgical evaluation

Susceptibility-weighted MR imaging of radiation therapy-induced cerebral microbleeds in patients with glioma: a comparison between 3T and 7T

Evaluation of Diagnostic and Prognostic Value of High-Resolution 3D 1H-MRSI for Patients with Newly Diagnosed Glioma

Synthesized 7T MPRAGE From 3T MPRAGE Using Generative Adversarial Network and Validation in Clinical Brain Imaging: A Feasibility Study

A paired dataset of T1- and T2-weighted MRI at 3 Tesla and 7 Tesla

Clinical image quality evaluation and comparison between different MRI equipment in the central nervous system

The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T

MR Imaging As a Precise Technique to Evaluate Skull-Base Tumor Volume: Comparison of CT, MR Imaging and FDG PET from Murine and Clinical Data.